Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hiatal hernia and gastroesophageal flap valve as diagnostic indicators in patients with gastroesophageal reflux disease.

Literature DB >> 16933016

Hiatal hernia and gastroesophageal flap valve as diagnostic indicators in patients with gastroesophageal reflux disease.

Yoshikazu Kinoshita, Kyoichi Adachi.

Abstract

Entities: Disease Species

Mesh：

Substances：
Proton Pump Inhibitors

Year: 2006 PMID： 16933016 DOI： 10.1007/s00535-006-1823-0

Source DB: PubMed Journal: J Gastroenterol ISSN： 0944-1174 Impact factor: 7.527

× No keyword cloud information.

11 in total

1. Endoscopic grading of the gastroesophageal valve in patients with symptoms of gastroesophageal reflux disease (GERD).

Authors: S Oberg; J H Peters; T R DeMeester; R V Lord; J Johansson; P F Crookes; C G Bremner
Journal: Surg Endosc Date: 1999-12 Impact factor: 4.584

2. Influence of Helicobacter pylori infection on the prevalence of reflux esophagitis in Japanese patients.

Authors: H Fujishiro; K Adachi; A Kawamura; T Katsube; M Ono; M Yuki; K Amano; S Ishihara; Y Kinoshita
Journal: J Gastroenterol Hepatol Date: 2001-11 Impact factor: 4.029

3. Gastroesophageal flap valve is associated with gastroesophageal and gastropharyngeal reflux.

Authors: Gwang Ha Kim; Dae Hwan Kang; Geun Am Song; Tae Oh Kim; Jeong Heo; Mong Cho; Jin Seon Kim; Byung Joo Lee; Soo Geun Wang
Journal: J Gastroenterol Date: 2006-07 Impact factor: 7.527

4. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly.

Authors: K Amano; K Adachi; T Katsube; M Watanabe; Y Kinoshita
Journal: J Gastroenterol Hepatol Date: 2001-02 Impact factor: 4.029

5. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese.

Authors: Ikuyo Mishima; Kyoichi Adachi; Noriyuki Arima; Kazutoshi Amano; Toshiharu Takashima; Makoto Moritani; Kenji Furuta; Yoshikazu Kinoshita
Journal: Scand J Gastroenterol Date: 2005-09 Impact factor: 2.423

6. The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan.

Authors: Yoshikazu Kinoshita; Takeaki Kobayashi; Mototsugu Kato; Kan Asahina; Ken Haruma; Tomohiko Shimatani; Shuji Inoue; Teppei Kabemura; Susumu Kurosawa; Hajime Kuwayama; Kiyoshi Ashida; Michiaki Hirayama; Satoshi Kiyama; Munemitsu Yamamoto; Junichi Suzuki; Hiroyuki Suzuki; Katsuhiko Matsumoto; Masaru Aoshima
Journal: J Gastroenterol Date: 2006-06 Impact factor: 7.527

7. Esophagogastric junction opening during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects.

Authors: John E Pandolfino; Guoxiang Shi; Brian Trueworthy; Peter J Kahrilas
Journal: Gastroenterology Date: 2003-10 Impact factor: 22.682

3. Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors.

Authors: Hideki Mizuno; Kazutoshi Yamada; Keiji Minouchi; Shinji Kamiyamamoto; Yoshinobu Hinoue
Journal: Biomed Rep Date: 2017-12-28

3 in total

Hiatal hernia and gastroesophageal flap valve as diagnostic indicators in patients with gastroesophageal reflux disease.

1. Endoscopic grading of the gastroesophageal valve in patients with symptoms of gastroesophageal reflux disease (GERD).

2. Influence of Helicobacter pylori infection on the prevalence of reflux esophagitis in Japanese patients.

3. Gastroesophageal flap valve is associated with gastroesophageal and gastropharyngeal reflux.

4. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly.

5. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese.

6. The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan.

7. Esophagogastric junction opening during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects.

8. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia.

Review 9. Therapeutic approaches to reflux disease, focusing on acid secretion.

10. Impairment of esophageal emptying with hiatal hernia.

1. Gastroesophageal flap valve status distinguishes clinical phenotypes of large hiatal hernia.

2. Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan.

3. Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors.